Inovio Pharmaceuticals, Inc. - Common Stock (INO)

EQNX::TICKER_START (NASDAQSBFM),NASDAQ:MRNANASDAQMRNA)(NYSE:PFENYSEPFE,(NASDAQ:VIRNASDAQ),(NASDAQ:INOINO) EQNX::TICKER_END

Novavax navigates legal settlements, earnings expectations, and competition, hoping their protein-based vaccines become a global health game-changer.

Plymouth Meeting, Pa., June 23, 2023 (GLOBE NEWSWIRE) --

PALM BEACH, Fla., Sept. 04, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The emergence of SARS-CoV-2, which triggered the COVID-19 pandemic with overall is widely regarded as the greatest medical emergency of the twentieth century. COVID-19’s impact on global society would be felt for a long time. Nonetheless, significant investment in life sciences in the last few decades has facilitated a rapid scientific response through advances in viral characterization, testing, and sequencing. A report from Transparency Market Research projects that the global COVID-19 therapeutics market size is projected to reach more than US$ 16.2 Bn by the end of 2031. The report continued: “The coronavirus treatment, and vaccination market witnessed significant increase in demand due to the desire of governments and people to safeguard themselves and their loved ones from the virus. Technology advancements have facilitated the rapid development of COVID medications therapies and vaccinations. In a relatively short amount of time, emerging technologies, such as CRISPR and mRNA, have made it possible to develop new medicines. Pharmaceutical corporations, biotech companies, academic institutions, and governmental entities have worked closely together to create COVID-19 treatments. New therapies and vaccines have been developed and distributed more rapidly because of this collaboration.” Active companies in the biotech industry this week include Sunshine Biopharma Inc. (NASDAQSBFM), Moderna, Inc. NASDAQ: MRNANASDAQMRNA)(NYSE: PFENYSEPFE, Vir Biotechnology, Inc. (NASDAQ: VIRNASDAQ), INOVIO (NASDAQ: INOINO).

EQNX::TICKER_START (NASDAQSBFM),NASDAQ:MRNANASDAQMRNA)(NASDAQ:NVAXNASDAQNVAX,(NASDAQ:VIRNASDAQ),(NASDAQ:INOINO) EQNX::TICKER_END

EQNX::TICKER_START (OTCQB:BIXT),(NASDAQNVAX),NYSE:PFENYSEPFE)(NASDAQ:MRNANASDAQMRNA,(NASDAQ:INONASDAQ),(NASDAQ:BNTXBNTX) EQNX::TICKER_END

Investing in biotech stocks carries both risk and reward. This article highlights two biotech companies that may appeal to specific investing styles

Amarin recently announced its earnings for Q2'22 with mixed results. Here we'll examine the pros and cons of having this penny stock in your portfolio.

Palm Beach, FL – January 20, 2022 – FinancialNewsMedia.com News Commentary – Cloud computing increases real-time data collection and improves accessibility to the data. It has outpaced the conventional paper healthcare system by providing more speed and efficiency in data handling. For instance, cloud computing technology is widely used in remote patient monitoring. Rising demand […]

FN Media Group Presents USA News Group News Commentary   Vancouver, BC –November 9, 2021 – USA News Group  –  After the launch of US President Joe Biden’s pushing of mandatory vaccination/testing in the workplace, new problems have arisen, such as expensive testing costs, and rampant supply shortages. On top of that, accuracy issues have […]

Palm Beach, FL – October 20, 2021 – FinancialNewsMedia.com News Commentary – Recently, scientific reports have shown that a universal coronavirus vaccine that protects against COVID-19 causing SARS-CoV-2, as well as other coronaviruses such as those causing SARS and MERS, produced promising results in a mouse study. Multiple SARS-CoV-2 vaccines have gone from development to […]

FN Media Group Presents USA News Group News Commentary   Vancouver, BC –October 6, 2021 – USA News Group  –  As vaccine passport programs continue to roll out in new markets across the globe, especially in Europe and North America, it appears that the argument remains unsettled, as vaccine in many parts of the world […]

Palm Beach, FL – September 23, 2021 – FinancialNewsMedia.com News Commentary – The growth in the COVID-19 vaccine market is projected to continue to surge through 2024. This growth is attributable to drastic surge in coronavirus cases across the world, in consort with combined efforts by regional governments and international organizations to support vaccine development as well as setup more of vaccination facilities. The growing government support for vaccine development and the increasing involvement of global organizations in the development of adequate vaccination facilities in endemic regions is anticipated to positively influence the sales of coronavirus vaccine in the upcoming years. Moreover, the strong demand for coronavirus vaccine, the ongoing initiative initiatives by governments to procure the vaccine and the waves of infection are likely to drive the market growth during the forecast period.  According to a report from Market Study Report said that Global Covid-19 vaccine Market will be valued at approximately USD 25 billion in the year 2024, while growing rapidly throughout.  The report said: “Under the Patient Type segment, Covid-19 market for senior citizens is anticipated to witness the largest market share owing to the focus of the governments to vaccinate the vulnerable population, manufacturing of vaccines being outsourced and also manufacturers collaborating with hospitals and doctors to better understand their demand and meet their requirements will be pushing growth in the market for Covid-19 vaccine during the coming years.  Active biotech companies in the market this week include BioVaxys Technology Corp. (OTCQB: BVAXF) (CSE: BIOV), Dynavax Technologies Corporation (NASDAQDVAX), INOVIO NASDAQ: INONASDAQINO)(NASDAQ: NVAXNASDAQNVAX, Vaxart, Inc. (NASDAQ: VXRTNASDAQ).

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Inovio Pharmaceuticals Inc. (NasdaqGS: INO).